TMEM52B and nonpapillary renal cell carcinoma: To investigate whether C12orf59 expression is correlated with the progression of ccRCC, the C12orf59 expression levels and the clinical pathological characteristics of 208 patients with ccRCC were compared by immunohistochemistry.